Companies like Forge Biologics, Sarepta Therapeutics, and Andelyn Biosciences might not be as well known in Central Ohio as a Honda or an Intel, but they too are putting our region on a highly coveted global map. They’re leaders in bioscience – the extremely complex, highly regulated, and yes – profitable – process of developing new drugs, therapies, and medical devices to treat disease and improve lives. More and more bioscience leaders are landing in Central Ohio, opening new research and manufacturing facilities that in turn attract more like them to Columbus. What’s the appeal of Central Ohio to bioscience firms, and how can we convince more to come? What is the promise of bioscience to revolutionize healthcare? Join us as we dissect the complexities, risk, and huge rewards of the bioscience business in Central Ohio.

Featuring Dr. Louise R. Rodino-Klapac, Executive Vice President, Head of R&D, Chief Scientific Officer, Sarepta; Dr. Frank Agbogbo, Vice President of Process Development, Forge Biologics; Robin Sears, President and CEO, LENTECHS; Dr. Erandi De Silva, Investment Partner, Drive Capital, with moderator Eddie Pauline, President and CEO, Ohio Life Sciences.